Bilirubin: An endogenous molecule with antiviral activity in vitro

Frontiers in Pharmacology

Volumn 3 MAR, Issue , 2012, Pages

  Santangelo, Rosaria ^a   Mancuso, Cesare ^a   Marchetti, Simona ^a   Di Stasio, Enrico ^a   Pani, Giovambattista ^a   Fadda, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Bilirubin; Biliverdin reductase; Enterovirus; Heme oxygenase; Herpes simplex virus; Nitric oxide

Indexed keywords

BILIRUBIN; HUMAN SERUM ALBUMIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; STRESS ACTIVATED PROTEIN KINASE;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; ENZYME PHOSPHORYLATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IN VITRO STUDY; VIRUS REPLICATION; VIRUS VIRULENCE;

EID: 84865986387     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00036     Document Type: Article

References (46)

1. Akaike, T., and Maeda,H. (2000). Nitric oxide and virus infection. Immunology 101, 300-308.
2. Asad, S. F., Singh, S., Ahmad, A., and Hadi, S. M. (1999). Bilirubin-Cu(II) complex degrades DNA. Biochim. Biophys. Acta 1428, 201-208.
3. Baranano, D. E., Rao, M., Ferris, C. D., and Snyder, S. H. (2002). Biliverdin reductase: a major physiologic cyto-protectant. Proc. Natl. Acad. Sci. U.S.A. 99, 16093-16098.
4. Berk, P. D., Howe, R. B., Bloomer, J. R., and Berlin, N. I. (1969). Studies of bilirubin kinetics in normal adults. J. Clin. Invest. 48, 2176-2190.
5. Bloomer, J. R., Berk, P. D., Howe, R. B., and Berlin, N. I. (1971). Interpretation of plasma bilirubin levels based on studies with radioactive bilirubin. JAMA 218, 216-220.
6. Bogdan, C., Rollinghoff, M., and Diefenbach, A. (2000). Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12, 64-76.
7. Coburn, R. F. (1970). Endogenous carbon monoxide production. N. Engl. J. Med. 282, 207-209.
8. Copeland, A. M., Newcomb, W. W., and Brown, J. C. (2009). Herpes simplex virus replication: roles of viral proteins and nucleoporins in capsid-nucleus attachment. J. Virol. 83, 1660-1668.
9. Croen, K. D. (1993). Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91, 2446-2452.
10. Davidge, K. S., Sanguinetti, G., Yee, C. H., Cox,A. G., Mcleod, C. W., Monk, C. E., Mann, B. E., Motterlini, R., and Poole, R. K. (2009). Carbon monoxide-releasing antibacterial molecules target respiration and global transcriptional regulators. J. Biol. Chem. 284, 4516-4524.
11. Desmard, M., Foresti, R., Morin, D., Dagoussat, M., Berdeaux, A., Dena-mur, E., Crook, S. H., Mann, B. E., Scapens, D., Montravers, P., Boczkowski, J., and Motterlini, R. (2012). Differential antibacterial activity against Pseudomonas aerug-inosa by carbon monoxide-releasing molecules. Antioxid. Redox Signal. 16, 153-163.
12. Fang, F. C. (2004). Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2, 820-832.
13. Fernandes, A., Falcao, A. S., Silva, R. F., Brito, M. A., and Brites, D. (2007). MAPKs are key players in mediating cytokine release and cell death induced by unconjugated bilirubin in cultured rat cortical astrocytes. Eur. J. Neurosci. 25, 1058-1068.
14. Fialkow, L., Wang, Y., and Downey, G. P. (2007). Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic. Biol. Med. 42, 153-164.
15. Hirschfield, G. M., and Alexander, G. J. (2006). Gilbert's syndrome: an overview for clinical biochemists. Ann. Clin. Biochem. 43, 340-343.
16. Horsfall, L. J., Rait, G., Walters, K., Swallow, D. M., Pereira, S. P., Nazareth, I., and Petersen, I. (2011). Serum bilirubin and risk of respiratory disease and death. JAMA 305, 691-697.
17. Hou, W. H., Rossi, L., Shan, Y., Zheng, J. Y., Lambrecht, R. W., and Bonkovsky, H. L. (2009). Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells. World J. Gastroen-terol. 15, 4499-4510.
18. Hrincius, E. R., Wixler, V., Wolff, T., Wagner, R., Ludwig, S., and Ehrhardt, C. (2010). CRK adaptor protein expression is required for efficient replication of avian influenza A viruses and controls JNK-mediated apoptotic responses. Cell. Microbiol. 12, 831-843.
19. Hung, H. C., Chen, T. C., Fang, M. Y., Yen, K. J., Shih, S. R., Hsu, J. T., and Tseng, C. P. (2010). Inhibition of enterovirus 71 replication and the viral 3D polymerase by aur-intricarboxylic acid. J. Antimicrob. Chemother. 65, 676-683.
20. Kaur, H., Hughes, M. N., Green, C. J., Naughton, P., Foresti, R., and Motterlini, R. (2003). Interaction of bilirubin and biliverdin with reactive nitrogen species. FEBS Lett. 543, 113-119.
21. Klespies, S. L., Cebula, D. E., Kelley, C. L., Galehouse, D., and Maurer, C. C. (1996). Detection of enteroviruses from clinical specimens by spin amplification shell vial culture and monoclonal antibody assay. J. Clin. Microbiol. 34, 1465-1467.
22. Koide, N., Naiki, Y., Morikawa, A., Tumurkhuu, G., Dagvadorj, J., Noman, A. S., Iftekar, E. K. I., Komatsu, T., Yoshida, T., and Yokochi, T. (2009). Nystatin-induced nitric oxide production in mouse macrophage-like cell line RAW264.7. Microbiol. Immunol. 53, 295-300.
23. Lehmann, E., El-Tantawy, W. H., Ocker, M., Bartenschlager, R., Lohmann, V., Hashemolhosseini, S., Tiegs, G., and Sass, G. (2010). The heme oxyge-nase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response. Hepatology 51, 398-404.
24. Maghzal,G.J., Leck,M.C.,Collinson, E., Li, C., and Stocker, R. (2009). Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase. J. Biol. Chem. 284, 29251-29259.
25. Maines, M. D. (1997). The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37, 517-554.
26. Maines, M. D. (2005). New insights into biliverdin reductase functions: linking heme metabolism to cell signaling. Physiology (Bethesda) 20, 382-389.
27. Mancuso, C., and Barone, E. (2009). The heme oxygenase/biliverdin reduc-tase pathway in drug research and development. Curr. Drug Metab. 10, 579-594.
28. Mancuso, C., Bonsignore, A., Capone, C., Di Stasio, E., and Pani, G. (2006a). Albumin-bound bilirubin interacts with nitric oxide by a redox mechanism. Antioxid. Redox Signal. 8, 487-494.
29. Mancuso, C., Pani, G., and Calabrese, V. (2006b). Bilirubin: an endogenous scavenger of nitric oxide and reactive nitrogen species. Redox Rep. 11, 207-213.
30. Mancuso, C., Capone, C., Ranieri, S. C., Fusco, S., Calabrese, V., Eboli, M. L., Preziosi, P., Galeotti, T., and Pani, G. (2008). Bilirubin as an endogenous modulator of neurotrophin redox signaling. J. Neurosci. Res. 86, 2235-2249.
31. Minetti, M., Mallozzi, C., Di Stasi, A. M., and Pietraforte, D. (1998). Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. Arch. Biochem. Biophys. 352, 165-174.
32. Mori, H., Otake, T., Morimoto, M., Ueba, N., Kunita, N., Nakagami, T., Yamasaki, N., and Taji, S. (1991). In vitro anti-human immunodeficiency virus type 1 activity of biliverdin, a bile pigment. Jpn. J. Cancer Res. 82, 755-757.
33. Nakagami, T., Taji, S., Takahashi, M., and Yamanishi, K. (1992). Antiviral activity of a bile pigment, biliverdin, against human herpesvirus 6 (HHV-6) in vitro. Microbiol. Immunol. 36, 381-390.
34. Nobre, L. S., Al-Shahrour, F., Dopazo, J., and Saraiva, L. M. (2009). Exploring the antimicrobial action of a carbon monoxide-releasing compound through whole-genome transcription profiling of Escherichia coli. Microbiology 155, 813-824.
35. Nobre, L. S., Seixas, J. D., Romao, C. C., and Saraiva, L. M. (2007). Antimicrobial action of carbon monoxide-releasing compounds. Antimicrob. Agents Chemother. 51, 4303-4307.
36. Prichard, M. N., Quenelle, D. C., Hartline, C. B., Harden, E. A., Jefferson, G., Frederick, S. L., Daily, S. L., Whitley, R. J., Tiwari, K. N., Maddry, J. A., Secrist, J. A. III, and Kern, E. R. (2009). Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides. Antimicrob. Agents Chemother. 53, 5251-5258.
37. Saijets, S., Ylipaasto, P., Vaarala, O., Hovi, T., and Roivainen, M. (2003). Enterovirus infection and activation of human umbilical vein endothelial cells. J. Med. Virol. 70, 430-439.
38. Stanberry, L. R., Floyd-Reising, S. A., Connelly, B. L., Alter, S. J., Gilchrist, M. J., Rubio, C., and Myers, M. G. (1994). Herpes simplex viremia: report of eight pediatric cases and review of the literature. Clin. Infect. Dis. 18, 401-407.
39. Stocker, R., Glazer, A. N., and Ames, B. N. (1987a). Antioxidant activity of albumin-bound bilirubin. Proc. Natl. Acad. Sci. U.S.A. 84, 5918-5922.
40. Stocker, R., Yamamoto, Y., Mcdonagh, A. F., Glazer, A. N., and Ames, B. N. (1987b). Bilirubin is an antioxidant of possible physiological importance. Science 235, 1043-1046.
41. Timmins, G. S., Master, S., Rusnak, F., and Deretic, V. (2004). Requirements for nitric oxide generation from isoniazid activation in vitro and inhibition of mycobacterial respiration in vivo. J. Bacteriol. 186, 5427-5431.
42. Tung, W. H., Hsieh, H. L., Lee, I. T., and Yang, C. M. (2011). Enterovirus 71 induces integrin beta1/EGFR-Rac1-dependent oxidative stress in SK-N-SH cells: role of HO-1/CO in viral replication(1). J. Cell. Physiol. 226, 3316-3329.
43. Verma, A., Hirsch, D. J., Glatt, C. E., Ronnett, G. V., and Snyder, S. H. (1993). Carbon monoxide: a putative neural messenger. Science 259, 381-384.
44. Vitek, L., Jirsa, M., Brodanova, M., Kalab, M., Marecek, Z., Danzig, V., Novotny, L., and Kotal, P. (2002). Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 160, 449-456.
45. Wu, L., and Wang, R. (2005). Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol. Rev. 57, 585-630.
46. Zhu, Z., Wilson, A. T., Luxon, B. A., Brown, K. E., Mathahs, M. M., Bandyopadhyay, S., Mccaffrey, A. P., and Schmidt, W. N. (2010). Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase? Hepatology 52, 1897-1905.